Pharmaceuticals
Skyrocketing demand for ADHD meds is straining the U.S. health care system
Stories about attention deficit hyperactivity disorder, or ADHD, have been having a resurgence in the social media zeitgeist the past several years, and it may be leading more people to seek out diagnosis for the condition. “A lot of my patients would hold up their phone to the camera and be like, ‘Here’s this video […]
Read More
What to watch for as J&J gets ready to split into two separate companies next year
Johnson & Johnson (JNJ) is preparing next year to spin off its consumer health unit into a publicly traded company separate from its pharmaceutical and medical technology operations. Ahead of the split, Morgan Stanley put out a research note, highlighting some of the debates in the market over the move, which would result in a […]
Read More
Biden administration will end monkeypox public health emergency
People line up to get a monkeypox vaccination at a new walk-up monkeypox vaccination site at Barnsdall Art Park on Tuesday, Aug. 9, 2022 in Hollywood, CA. Brian Van Der Brug | Los Angeles Times | Getty Images The Biden administration will end the public health emergency declared in response to the monkeypox outbreak, as […]
Read More
Alzheimer’s drug trial shown to slow cognitive decline in long fight against dementia
Alzheimer’s is the most common form of dementia, a general term for loss of memory, language, and other thinking abilities Brian B. Bettencourt | Toronto Star | Getty Images A trial of an experimental Alzheimer’s drug has been hailed as a “new era” in the beleaguered fight to find a cure for dementia. Results from […]
Read More
Earth Health Group to rename monkeypox as mpox
The identify mpox, otherwise known as Mpox, was picked out just after the WHO introduced a community session method before this year. Orlando Sentinel | Tribune News Provider | Getty Visuals The Environment Health and fitness Business claimed Monday that it would start out referring to monkeypox as mpox in an exertion to reduce stigma […]
Read More
Why flu season is so bad this year
If it seems like everyone around you is getting sick, you’re not imagining it. The flu season is hitting the United States unusually early and much harder than it usually does. “I’m scared about what’s going to happen this flu season because I don’t think we’ve ever seen a coalition of multiple viruses kind of […]
Read More
Mindfulness meditation reduces anxiety as much as a common antidepressant drug, study finds
Mindfulness meditation is as effective at reducing anxiety as a commonly prescribed antidepressant, according to a study published in a major journal on Wednesday. The study, led by researchers at Georgetown University Medical Center, is the first randomized clinical trial to compare the effectiveness of mindfulness meditation with the antidepressant escitalopram. The results were published […]
Read More
Two portfolios—one GOP, 1 Democrat—make predictions about the U.S. midterms
ShareShare Posting by using FacebookShare Article via TwitterShare Report by way of LinkedInShare Posting by using E mail Electricity, defense, insurance coverage and pharmaceutical stocks will advantage from insurance policies set by the Republicans. Clean up electricity is a winner if the Democrats excel. As well as, the latest on the midterms and help to […]
Read More
4 of our stocks are in the news. Here’s the Club’s take on each development
Four of our Club holdings — Costco Wholesale (COST), Amazon (AMZN), Humana (HUM) and Bausch Health (BHC) — were in the news Thursday. Here’s how we feel about the developments. Costco The news: Costco reported sales for the retail month of October after the closing bell Wednesday evening. In the four-week period, net sales increased 7.7% […]
Read More
CVS Health raises outlook as third quarter results beat estimates
Rafael Henrique | Lightrocket | Getty Images CVS Health reported third quarter earnings Wednesday morning that beat Wall Street’s expectations. Here’s how the pharmacy giant performed compared to Wall analysts’ estimates, according to Refinitiv: Earnings per share $2.09 vs. $1.99, expected. Revenue $81.16 billion vs. $76.75 billion, expected. It’s the third consecutive quarter in which […]
Read More